Skip to search formSkip to main contentSkip to account menu

del(17p13)

Known as: -17p13, 17p13 Deletion, Del(17)(p13) 
A deletion of chromosomal material at 17p13. This chromosomal aberration includes deletion of the TP53 gene and is associated with multiple myeloma… 
National Institutes of Health

Related topics

Related topics

17 relations

Broader (1)

17p13
Aleukemic Chronic Lymphocytic LeukemiaChromosomes, Human, Pair 17Chronic Lymphocytic Leukemia with Plasmacytoid DifferentiationChronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Bruton tyrosine kinase inhibition in chronic lymphocytic leukemia.
Chronic lymphocytic leukemia (CLL) is the most common adult leukemia and remains incurable outside of the setting of allogeneic… 
Review
2015
Review
2015
Management of chronic lymphocytic leukemia.
Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) is usually diagnosed in asymptomatic patients with early-stage… 
2014
2014
Chemoimmunotherapy for relapsed/refractory and progressive 17p13‐deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low‐dose rituximab is effective and tolerable and…
Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) patients with purine analog refractory disease or TP53 dysfunction… 
2014
2014
Retrospective analysis of genetic abnormalities and survival in 131 patients with multiple myeloma
Genetic abnormalities in patients with multiple myeloma (MM) are important risk factors in terms of prognosis. In the present… 
Highly Cited
2012
Highly Cited
2012
Different distribution of NOTCH1 mutations in chronic lymphocytic leukemia with isolated trisomy 12 or associated with other chromosomal alterations
Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults in Western countries. Chromosomal abnormalities… 
2010
2010
Centrosome amplification as a possible marker of mitotic disruptions and cellular carcinogenesis in multiple myeloma.
2009
2009
Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high‐dose chemotherapy and autologous stem cell transplantation
High‐dose chemotherapy followed by autologous stem cell transplantation (ASCT) is a standard therapy for newly diagnosed multiple… 
Review
2007
Review
2007
Review of molecular diagnostics in multiple myeloma
Multiple myeloma evolves clinically from monoclonal gammopathy of undetermined significance through smoldering disease, active… 
2004
2004
New chromosomal syndrome: Miller-Dieker syndrome and monosomy 17p13
SummaryThe Miller-Dieker Syndrome (MDS) consists of lissencephaly, characteristic facies, pre- and postnatal growth retardation… 
Highly Cited
2002
Highly Cited
2002
Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
BACKGROUND AND OBJECTIVES Chromosome 11q22.3-23.1 deletions involving the ataxia-teleangiectasia mutated (ATM) locus (11q-/ATM… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)